Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 769,000 | 1,247,800 | 1,198,100 | 1,030,900 | 862,800 |
| Marketable Securities | 446,300 | 490,900 | 317,700 | 465,000 | 604,000 |
| Receivables | 699,100 | 661,400 | 679,200 | 686,200 | 664,900 |
| Inventories | 875,500 | 757,800 | 740,000 | 730,600 | 726,700 |
| Other current assets | 195,900 | 267,600 | 248,800 | 234,500 | 237,100 |
| TOTAL | $3,095,800 | $3,513,900 | $3,263,100 | $3,241,300 | $3,180,700 |
| Non-Current Assets | |||||
| PPE Net | 1,632,800 | 1,566,400 | 1,559,900 | 1,552,200 | 1,546,600 |
| Investments And Advances | 1,239,000 | 1,381,000 | 1,490,800 | 1,623,700 | 1,834,200 |
| Intangibles | 1,449,500 | 1,425,200 | 1,484,800 | 1,488,300 | 1,491,500 |
| Other Non-Current Assets | 875,400 | 751,700 | 626,500 | 514,400 | 449,600 |
| TOTAL | $5,196,700 | $5,124,300 | $5,162,000 | $5,178,600 | $5,321,900 |
| Total Assets | $8,292,500 | $8,638,200 | $8,425,100 | $8,419,900 | $8,502,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 201,900 | 154,900 | 162,500 | 158,800 | 204,500 |
| Accrued Expenses | 795,000 | 739,500 | 783,300 | 767,200 | 802,300 |
| TOTAL | $1,022,400 | $917,900 | $969,100 | $949,900 | $1,032,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 596,300 | 596,200 | 596,000 | 595,900 | 595,700 |
| Other Non-Current Liabilities | 867,100 | 906,300 | 916,400 | 1,029,200 | 1,038,700 |
| TOTAL | $1,463,400 | $1,502,500 | $1,512,400 | $1,625,100 | $1,634,400 |
| Total Liabilities | $2,485,800 | $2,420,400 | $2,481,500 | $2,575,000 | $2,666,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 608,313 | 618,261 | 619,943 | 621,752 | 623,207 |
| Common Shares | 646,300 | 645,700 | 645,000 | 642,900 | 642,000 |
| Retained earnings | 7,590,000 | 7,191,600 | 6,848,100 | 6,441,700 | 6,068,100 |
| Other shareholders' equity | -254,900 | -256,000 | -224,000 | -186,100 | -157,600 |
| TOTAL | $5,806,700 | $6,217,800 | $5,943,600 | $5,844,900 | $5,835,900 |
| Total Liabilities And Equity | $8,292,500 | $8,638,200 | $8,425,100 | $8,419,900 | $8,502,600 |